Dong-A expands in painkiller market

Boosted by robust sales of a new isopropylantipyrine (IPA)-free painkiller “Amcilon Q”, Dong-A Pharm is attempting to become a leading player in the domestic analgesic market, which has been dominated by Samjin’ Geworon, Chong Kun Dang’s Penzal and Janssen Korea’s Tylenol.

While Samjin and Chong Kun Dang are on the defensive this time, Dong-A and Janssen Korea have extensive waged an extensi...